At best, allergies can reduce the quality of life. At worst, they can be life threatening. For these reasons, Allergy Therapeutics go beyond symptom management and directly treat the cause of the allergy.

The company is a market leader within the immunology business, with specialist experience in the research and development of allergy treatments. Transformational outcomes for patients is achieved by directly treating the cause of the allergy, rather than just managing the symptoms. The company’s portfolio ranges from sublingual treatments and subcutaneous treatments to diagnostics.

The company’s products are mainly sold in European countries and products in clinical development include vaccines for grass, tree and house dust mites, as well as a peanut allergy vaccine that is in pre-clinical development. Adjuvant systems to boost performance of vaccines outside of allergy are also in the pipeline.